Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
Impact of age and gender on the clinicopathological characteristics of bladder cancer
Indian Journal of Urology, 06/25/09
Gupta P et al. - Data suggest that transitional cell carcinoma (TCC) is the predominant cancer, with significant male preponderance among Indian patients. Younger patients have low-grade disease; hematuria is the most common presentation. Greater awareness is needed not to overlook bladder cancer.
Methods- Study to determine the impact of age and gender on the clinicopathological characteristics of histologically confirmed bladder cancer in India
- From Jan 2001-June 2008, records of pts (n=561) with bladder cancer were evaluated for:
- Age and gender at presentation
- Clinical symptoms
- Cystoscopic finding
- History of smoking, and
- Histopathological characteristics
- 97% of the pts presented with painless hematuria
- Mean age: 60.2 ± 4.4 yrs; male to female ratio: 8.6:1
- TCC was the most common histological variety, which was present in 97.71% of the pts
- 26% pts had muscle invasive disease at the time of presentation:
- However, 34.5% pts did not show any evidence of detrusor muscle
- In pts with nonmuscle-invasive bladder carcinoma, 55% had p Ta while 45% had p T1
- Overall, 44.7% pts had low-grade disease
- Among pts <60 yrs, low-grade and low-stage disease were more prevalent vs those >60 yrs
- Incidence of smoking was much higher among males vs females
Today in Bladder...keeping you current
Receive free subspecialty "5-minute updates" via email
Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: Evaluation of efficacy and tolerance
Journal of Clinical Oncology, 10/26/09
Fesoterodine: a new antimuscarinic for overactive bladder
Aging Health, 10/13/09
Frequently asked questions in the evaluation and management of overactive bladder
The Journal of Family Practice, 11/02/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
Zinc and prostatic cancer
Current Opinion in Clinical Nutrition & Metabolic Care, 10/14/09
Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy
Annals of Oncology, 10/16/09
Article Search
Sponsor


See Latest Articles


